OFTAQUIX

This brand name is authorized in Austria, Estonia, Finland, Lithuania, Malta, Poland, Romania, United Kingdom

Active ingredients

The drug OFTAQUIX contains one active pharmaceutical ingredient (API):

1 Levofloxacin UNII 6GNT3Y5LMF - LEVOFLOXACIN

Levofloxacin is a synthetic antibacterial agent of the fluoroquinolone class. As a fluoroquinolone antibacterial agent, levofloxacin acts on the DNA – DNA-gyrase complex and topoisomerase IV. Read about Levofloxacin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
OFTAQUIX Eye drops, solution	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
S01AE05		S Sensory organs → S01 Ophthalmologicals → S01A Antiinfectives → S01AE Fluoroquinolones
Discover more medicines within S01AE05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1168051
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 010573, 085205
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 101993, 335503, 399694
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1018081, 1084592
Country: MT	Medicines Authority	Identifier(s): AA1068/00401
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100127766, 100231825, 100264339, 100329524, 100347893, 100377463, 100383469, 100394734, 100414081, 100437857
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W58640001